Log in or Sign up for Free to view tailored content for your specialty!
Vasculitis and Giant Cell Arteritis News
Temporal artery ultrasound, EULAR criteria reliable diagnostics for giant cell arteritis
KIAWAH ISLAND, S.C. — Temporal artery ultrasound and EULAR score are reliable means for diagnosing giant cell arteritis, Mercy Bechtold, MD, said during her presentation at Kiawah Eye.
VIDEO: What to look for in leukocytoclastic vasculitis
CLEVELAND — In this video perspective from the Cleveland Clinic’s Medical Dermatology Therapy Update III meeting, Adam Brown, MD, a rheumatologist at the institution, discusses what to look for in leukocytoclastic, or cutaneous, vasculitis.
Log in or Sign up for Free to view tailored content for your specialty!
Tocilizumab taper 'reasonable' in giant cell arteritis remission despite flare risk
DESTIN, Fla. — Rheumatologists should consider tapering tocilizumab for patients with giant cell arteritis in remission despite the increased risk for flare, said a speaker at the Congress of Clinical Rheumatology East annual meeting.
Despite advancements, EPGA management often remains 'a bit of a mystery'
DESTIN, Fla. — Treating respiratory and systemic manifestations of eosinophilic granulomatosis with polyangiitis can be effective despite an incomplete understanding of the disease, said a speaker at the Congress of Clinical Rheumatology East.
Henoch-Schönlein purpura incidence fell, rose with COVID-19 protective measures
Incidence of Henoch-Schönlein purpura waned and waxed significantly with the implementation and relaxation of non-pharmaceutical interventions against COVID-19, according to data published in JAMA Network Open.
Giant cell arteritis diagnoses made via temporal artery ultrasound maintained at 2 years
All diagnoses of giant cell arteritis made through temporal artery ultrasound were unchanged at 1 month — and at 2 years, for those with available data — in a study published in Annals of Internal Medicine.
Prediction tool combining clinical probability, ultrasound confirms GCA from mimics
A new metric reliably confirms giant cell arteritis in suspected cases by combining a validated clinical scoring tool with ultrasonography, according to data in The Lancet Rheumatology.
Nearly half of patients with giant cell arteritis achieve remission with upadacitinib
Nearly half of patients with giant cell arteritis who received upadacitinib while tapering steroids achieved remission from weeks 12 through 52 in a phase 3 trial, according to a press release from AbbVie.
SNOT-22 questionnaire predicts ANCA-associated vasculitis relapse risk up to 2 years
Higher scores on a measure of sinonasal symptoms can predict ANCA-associated vasculitis relapse “months to years” ahead of time, according data published in Arthritis Care & Research.
Urticarial Vasculitis, Part 2: Walking the Balance Beam of Allergy and Rheumatology
This episode digs into the pathophysiology of urticaria vasculitis from anti-C1q to the story of bradykinin.
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read
-
Headline News
Expected drop in HIV care providers may signal potential shift to primary care physicians
November 11, 20242 min read -
Headline News
Q&A: What to know about surge of ‘walking pneumonia’ in children
November 09, 20244 min read -
Headline News
Racial gaps in preemptive living donor kidney transplant persist during last 2 decades
November 12, 20241 min read